Abstract
Modification of the human genome has immense potential for preventing or treating dis-ease. Modern genome editing techniques based on CRISPR/Cas9 show great promise for altering disease‐relevant genes. The efficacy of precision editing at CRISPR/Cas9‐induced double‐strand breaks is dependent on the relative activities of nuclear DNA repair pathways, including the ho-mology‐directed repair and error‐prone non‐homologous end‐joining pathways. The competition between multiple DNA repair pathways generates mosaic and/or therapeutically undesirable editing outcomes. Importantly, genetic models have validated key DNA repair pathways as druggable targets for increasing editing efficacy. In this review, we highlight approaches that can be used to achieve the desired genome modification, including the latest progress using small molecule mod-ulators and engineered CRISPR/Cas proteins to enhance precision editing.
Original language | English |
---|---|
Article number | 8571 |
Pages (from-to) | 1-18 |
Number of pages | 18 |
Journal | International Journal of Molecular Sciences |
Volume | 22 |
Issue number | 16 |
DOIs | |
Publication status | Published - 2 Aug 2021 |
Bibliographical note
Copyright the Author(s) 2021. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.Keywords
- CRISPR/Cas9
- Engineered Cas9
- Genome editing
- Homology‐directed repair
- Small molecules